Researchers have identified a molecule found in tree frogs as a pharmacolical agent to stimulate the development of insulin-producing cells. This could be a ground-breaking discovery for the treatment of Type 1 diabetes. Dr. Fred Levine speaks with me about this unorthodox approach to generate insulin-producing cells. This exciting work is being done at Sanford Children’s Health Research Center at Sanford-Burnham.
Researchers have been able to identify what children may be at a higher risk for developing Type 1 diabetes. Given the higher risk predisposition, why is it some people develop T1D and others do not? Dr. Jessica Dunne, Senior Scientist of Prevention at JDRF, speaks with me about the work being done to better understand and correct the immune vulnerability related to T1D.
American Diabetes Association grant winner, Dr. Lauren Sparks, is an investigator at the Translational Research Institute for Metabolism and Diabetes. She tells me about her work to understand the mechanism of exercise in the body and how diabetes can affect the normal response to exercise.
The "holy grail" of basal insulin analogues would have vast duration, a gently rolling profile, and
natural beauty in delivery. Peglispro is a novel basal insulin analog that may wear the crown. It is being studied for the treatment of Type 1 and Type 2 diabetes. Dr. David Kendall, distinguished medical fellow, Lilly Diabetes, speaks about the potential paradigm shifting basal insulin analog that may provide better glucose control and weight loss in people with diabetes.
Bones are important for support, protection, and mobility of the body. Diabetes can affect the body, including the bones. Dr. Shannon Wallet, Associate Professor at the University of Florida College of Dentistry, speaks with me about her work, funded by the American Diabetes Association, to better understand the mechanism of this impairment in people with diabetes and what can be done to replenish the weakness in diabetic bones.
People with diabetes are victims of circumstance when it comes to blood glucose testing. To possibly rescue the bloodshed for all people with diabetes, Avner Gal, the CEO of Integrity Applications speaks with me about GlucoTrack, a noninvasive device to measure blood glucose.
The pain of diabetic neuropathy has yet to be effectively treated with a non-pill therapy. SENSUS Pain Management System is a non-invasive, electrical nerve stimulator designed to alleviate the chronic pain of diabetic neuropathy. We speak with the founder and CEO of NeuroMetrix, Dr. Shai Gozani, about the FDA cleared SENSUS device.
A Type 1 diabetes cure is conditional on finding a reliable source of islet cells. Stem cells have been mentioned as a potential source but not all stem cells can become insulin-producing cells Researchers have identified that stem cells harvested from the biliary tree have the potential to become insulin-producing cells. Dr. Giancomo Lanzoni, Research Scholar at the Diabetes Research Institute, tells us about this exciting discovery.
The common belief of people with Type 1 diabetes is that they cannot produce insulin. Based on the findings in a study out of University of Exeter Medical School, 75% of people with T1D can stimulate insulin production. We speak with Dr. Richard Oram, lead investigator in this thought-provoking study about his findings and what this could mean for our understanding of T1D.
The Mimined 530G with Enlite is the first insulin pump system in the US that offers superior glucose control by integrating a continuous glucose monitor that it is designed to stop delivering insulin when the sensor glucose drops to a preset low threshold. We speak with John Mastrototaro Vice President of Research and Development at Medtronic Diabetes, to learn more about this first generation artificial pancreas system with Threshold Suspend.